Jefferies Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-462,300
Closed -$11.5M – 2102
2025
Q4
$11.5M Buy
462,300
+255,000
+123% +$6.43M 0.06% 288
2025
Q3
$5.28M Buy
207,300
+150,000
+262% +$3.7M 0.02% 358
2025
Q2
$1.39M Hold
57,300
– – 0.01% 627
2025
Q1
$1.45M Buy
+57,300
New +$1.5M 0.01% 669
2024
Q2
– Sell
-75,100
Closed -$2.08M – 1773
2024
Q1
$2.08M Sell
75,100
-51,100
-40% -$1.42M 0.02% 582
2023
Q4
$3.63M Buy
+126,200
New +$3.81M 0.02% 494
2023
Q1
– Sell
-60,000
Closed -$3.07M – 1905
2022
Q4
$3.07M Buy
+60,000
New +$2.88M 0.02% 510

Other funds holding PFE

Jefferies Financial Group's PFE Position: Q2 2026 in Review

Jefferies Financial Group reduced its Pfizer (PFE) stake by 30% in Q2 2026, selling an estimated $7.36M and leaving 642,123 shares worth $15.5M. The position accounts for 0.1% of the portfolio, ranked #181.

Jefferies Financial Group first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $35.3M in Q4 2024. 2,839 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Jefferies Financial Group held 642,123 shares of Pfizer worth $15.5M as of Q2 2026.
  • Jefferies Financial Group sold 281,197 Pfizer shares in Q2 2026, an estimated $7.36M.
  • Pfizer made up 0.1% of Jefferies Financial Group's portfolio in Q2 2026, its #181 holding.
  • Jefferies Financial Group first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Jefferies Financial Group's Pfizer position peaked at $35.3M in Q4 2024.
  • 2,839 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.